TCM
LUMO

Tradewinds Capital Management’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

Tradewinds Capital Management’s Portfolio LUMO Stock Details LUMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-169
Closed -$83K – 696
2015
Q1 		$83K Hold
169
– – 0.06% 165
2014
Q4 		$61K Buy
169
+2
+1% +$595 0.04% 189
2014
Q3 		$32K Buy
+167
New +$36.7K 0.02% 250

Other funds holding LUMO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
GAM
Gotham Asset Management New York $32.7B AUM 27.65% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
TAM
Tiverton Asset Management Wilimington, Delaware $2.88B AUM 5.6% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Tradewinds Capital Management's LUMO Position: Q2 2015 in Review

Tradewinds Capital Management sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q2 2015, closing a stake of 169 shares — an estimated $83K sold.

Tradewinds Capital Management first reported a position in LUMO in Q3 2014 and held it in 3 quarters. The position peaked at $83K in Q1 2015. 145 funds tracked by Wall St. Rank hold LUMO as of Q2 2015.

  • Tradewinds Capital Management reported no remaining Lumos Pharma, Inc. Common Stock position as of Q2 2015 after selling out during the quarter.
  • Tradewinds Capital Management sold 169 Lumos Pharma, Inc. Common Stock shares in Q2 2015, an estimated $83K.
  • Tradewinds Capital Management first reported a position in Lumos Pharma, Inc. Common Stock in Q3 2014 and held it in 3 quarters.
  • Tradewinds Capital Management's Lumos Pharma, Inc. Common Stock position peaked at $83K in Q1 2015.
  • 145 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q2 2015.

Based on Tradewinds Capital Management's 13F filing for Q2 2015, filed 30 Jul 2015.